Effect of eicosapentaenoic acid on central systolic blood pressure

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 88, Issue 2, 2013, Pages 191-195

  Iketani, Toshiro ^a   Takazawa, Kenji ^b   Yamashina, Akira ^b  

^a Department of Internal Medicine   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Augmentation index; Blood pressure; Central systolic blood pressure; Eicosapentaenoic acid

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUGMENTATION INDEX; CENTRAL SYSTOLIC BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HEART AFTERLOAD; HEART RATE; HUMAN; HYPERLIPIDEMIA; MALE; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD PRESSURE; EICOSAPENTAENOIC ACID; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PRAVASTATIN;

EID: 84875812559     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2012.11.008     Document Type: Article

References (29)

1. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Prospective studies collaboration. age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
2. Glorioso N., Manunta P., Filigheddu F., Troffa C., Stella P., Barlassina C., Lombardi C., Soro A., Dettori F., Arpaglia P.P., Alibrandi M.T., Cusi D., Bianchi G. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension 1999, 34:1281-1286.
3. Spósito A.C., Mansur A.P., Coelho O.R., Nicolau J.C., Ramires J.A. Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors enalapril or lisinopril. Am. J. Cardiol. 1999, 83:1497-1499.
4. Borghi C., Prandin M.G., Costa F.V., Bacchelli S., Esposti D.Degli, Ambrosioni E. Use of statins and blood pressure control in treated hypertensive patients with hypercholesterolemia. J. Cardiovasc. Pharmacol. 2000, 35:549-555.
5. Ichihara A., Hayashi M., Koura Y., Tada Y., Kaneshiro Y., Saruta T. Long-term effects of statins on arterial pressure and stiffness of hypertensives. J. Human Hypertension 2004, 19:103-109.
6. Miyajima T., Tsujino T., Saito K., Yokoyama M. Effect of eicosapentaenoic acid on blood pressure, cell membrane fatty acids, and intracellular sodium concentration in essential hypertension. Hypertension Res. 2001, 24:537-542.
7. Geleijnse J.M., Giltay E.J., Grobbee D.E., Donders A.R., Kok F.J. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertension 2002, 20:1493-1499.
8. Kaesemeyer W.H., Caldwell R.B., Huang J., Caldwell R.W. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J. Am. Coll. Cardiol. 1999, 33:234-241.
9. Nickenig G., Nickenig G., Roeling J., Wassmann S., Zolk O., Knorr A., Bohm M. Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation 1999, 100:2131-2134.
10. Wassmann S., Laufs U., Baumer A.T., Muller K., Ahlbory K., Linz W., Itter G., Rosen R., Bohm M., Nickenig G. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension 2001, 37:1450-1457.
11. Lawson D.L., Mehta J.L., Saldeen K., Mehta P., Saldeen T.G. Omega-3 polyunsaturated fatty acids augment endothelium-dependent vasorelaxation by enhanced release of EDRF and vasodilator prostaglandins. Eicosanoids 1991, 4:217-223.
12. Okuda Y., Kawashima K., Sawada T., Tsurumaru K., Asano M., Suzuki S., Soma M., Nakajima T., Yamashita K. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem. Biophys Res. Commun. 1997, 232:487-491.
13. Collie-Duguid ES E.S., Wahle K.W. Inhibitory effect of fish oil N-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules. Biochem. Biophys. Res. Commun. 1996, 220:969-974.
14. Wander R.C., Du S.H., Thomas D.R. Influence of long-chain polyunsaturated fatty acids on oxidation of low density lipoprotein. Prostaglandins Leukot. Essent. Fatty Acids 1998, 59:143-151.
15. Williams B., Lacy P.S., Thom S.M., Cruickshank K., Stanton A., Collier D., Hughes A.D., Thurston H. M. O'Rourke; for the CAFE investigators; Anglo-Scandinavian cardiac outcomes trial investigators; CAFE steering committee and writing committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation 2006, 113:1213-1225.
16. Yaginuma T., Noda T., Tsuchiya M., Takazawa K., Tanaka H., Kotoda K., Hosoda S. Interaction of left ventricular contraction and aortic input impedance in experimental and clinical studies. Jpn. Circ. J. 1985, 49:206-214.
17. Takazawa K., Tanaka N., Takeda K., Kurosu F., Ibukiyama C. Underestimation of vasodilator effects of nitroglycerin by upper limb blood pressure. Hypertension 1995, 26:520-523.
18. Pini R., Cavallini M.C., Palmieri V., Marchionni N., Di Bari M., Devereux R.B., Masotti G., Roman M.J. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J. Am. Coll. Cardiol. 2008, 51:2432-2439.
19. Takazawa K., Kobayashi H., Shindo N., Tanaka N., Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertension Res. 2007, 30:219-228.
20. Wilkinson I.B., MacCallum H., Flint L., Cockcroft J.R., Newby D.E., Webb D.J. The influence of heart rate on augmentation index and central arterial pressure in humans. J. Physiol. 2000, 525:263-270.
21. Sekiya M., Yahagi N., Matsuzaka T., Najima Y., Nakakuki M., Nagai R., Ishibashi S., Osuga J., Yamada N., Shimano H. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 2003, 38:1529-1539.
22. Hun C.S., Hasegawa K., Kawabata T., kato M., Shimokawa T., Kagawa Y. Increased uncoupling protein 2 mRNA in white adipose tissue, and decrease in leptin, visceral fat, blood glucose, and cholesterol in KK-Ay mice fed with eicosapentaenoic acid and docosahexaenoic acid in addition to linolenic acid. Biochem. Biophys. Res. Commun. 1999, 282:1352-1359.
23. Ghafoorunissa, Ibrahim A., Rajkumar L., Acharya V. Dietary(n-3) long chain polyunsaturated fatty acids prevent sucrose-induced insulin resistance in rats. J. Nutr. 2005, 135:2634-2638.
24. Omura M., Kobayashi S., Mizukami Y., Mogami K., Todoroki-Ikeda N., Miyake T., Matsuzaki M. Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation. FEBS Lett. 2001, 487:361-366.
25. Tagawa T., Hirooka Y., Shimokawa H., Hironaga K., Sakai K., Oyama J., Takeshita A. Long-term treatment with eicosapentaenoic acid improves exercise-induced vasodilation in patients with coronary artery disease. Hypertension Res. 2002, 25:823-829.
26. Sato M., Katsuki Y., Kanehiro H., Iimura M., Akada Y., Mizota M., Kunihiro Y. Effects of ethyl all-cis-5,8,11,14,17- icosapentaenoate on the physical properties of arterial walls in high cholesterol diet-fed rabbits. J. Cardiovasc. Pharmacol. 1993, 22:1-9.
27. Tomiyama H., Takazawa K., Osa S., Hirose K., Hirai A., Iketani T., Monden M., Sanoyama K., Yamashina A. Do eicosapentaenoic acid supplements attenuate age-related increases in arterial stiffness in patients with dyslipidemia?: A preliminary study. Hypertension Res. 2005, 28:651-655.
28. Yokoyama M., Origasa H., Matsuzaki M., Matsuzawa Y., Saito Y., Ishikawa Y., Oikawa S., Sasaki J., Hishida H., Itakura H., Kita T., Kitabatake A., Nakaya N., Sakata T., Shimada K., Shirato K. Japan E.P.A. lipid intervention study (JELIS) Investigators, Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 2007, 369:1090-1098.
29. Ueshima H., Stamler J., Elliott P., Chan Q., Brown I.J., Carnethon M.R., Daviglus M.L., He K., Moag-Stahlberg A., Rodriguez B.L., Steffen L.M., Van Horn L., Yarnell J., Zhou B. For the INTERMAP research group, food omega-3 fatty acids lower blood pressure and should impact heart disease/dyslipidemia, study finds. Hypertension 2007, 50:1-7.